There have been 50 recent insider transactions recorded for GeoVax Labs, Inc. (GOVX), including 49 buys and 0 sells. Total insider buying was valued at $2.42M and total insider selling at RSU Award.
Notable insiders with recent activity include Mckee Kelly T. Jr., Mcnally Robert T, Chase Randal D. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — GOVX
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2025-08-07 |
Mckee Kelly T. Jr. |
Chief Medical Officer |
Informative Buy |
1,107 |
$0.67 |
$741.69 |
3,494 |
| 2025-06-05 |
Mcnally Robert T |
Director |
RSU Award |
10,000 |
$2.48 |
$24.8K |
10,000 |
| 2025-06-05 |
Chase Randal D |
Director |
RSU Award |
10,000 |
$2.48 |
$24.8K |
10,000 |
| 2025-06-05 |
Dodd David A |
President, CEO |
RSU Award |
185,500 |
$2.48 |
$460.04K |
185,500 |
| 2025-06-05 |
Newman Mark J |
Chief Scientific Officer |
RSU Award |
70,000 |
$2.48 |
$173.6K |
70,000 |
| 2025-06-05 |
Spencer John N Jr |
Director |
RSU Award |
10,000 |
$2.48 |
$24.8K |
10,000 |
| 2025-06-05 |
Reynolds Mark |
CFO |
RSU Award |
70,000 |
$2.48 |
$173.6K |
70,000 |
| 2025-06-05 |
Kollintzas Dean G |
Director |
RSU Award |
10,000 |
$2.48 |
$24.8K |
10,000 |
| 2025-06-05 |
Sharkey John W. |
VP, Business Development |
RSU Award |
70,000 |
$2.48 |
$173.6K |
70,000 |
| 2025-06-05 |
Mckee Kelly T. Jr. |
Chief Medical Officer |
RSU Award |
70,000 |
$2.48 |
$173.6K |
70,000 |
| 2025-06-05 |
Lemerond Nicole |
Director |
RSU Award |
10,000 |
$2.48 |
$24.8K |
10,000 |
| 2025-06-05 |
Morgan Jayne |
Director |
RSU Award |
10,000 |
$2.48 |
$24.8K |
10,000 |
| 2025-04-10 |
Sharkey John W. |
VP, Business Development |
Informative Buy |
6,000 |
$0.99 |
$5.94K |
6,191 |
| 2025-04-10 |
Spencer John N Jr |
Director |
Informative Buy |
10,000 |
$0.98 |
$9.8K |
11,402 |
| 2025-04-01 |
Dodd David A |
President, CEO |
Informative Buy |
10,000 |
$1.08 |
$10.8K |
36,661 |
| 2025-03-31 |
Reynolds Mark |
CFO |
Informative Buy |
6,800 |
$1.08 |
$7.34K |
14,013 |
| 2024-08-12 |
Mcnally Robert T |
Director |
RSU Award |
8,050 |
$2.17 |
$17.47K |
8,050 |
| 2024-08-12 |
Chase Randal D |
Director |
RSU Award |
8,050 |
$2.17 |
$17.47K |
8,050 |
| 2024-08-12 |
Dodd David A |
President, CEO |
RSU Award |
35,000 |
$2.17 |
$75.95K |
35,000 |
| 2024-08-12 |
Newman Mark J |
Chief Scientific Officer |
RSU Award |
15,700 |
$2.17 |
$34.07K |
15,700 |
| 2024-08-12 |
Spencer John N Jr |
Director |
RSU Award |
8,050 |
$2.17 |
$17.47K |
8,050 |
| 2024-08-12 |
Reynolds Mark |
CFO |
RSU Award |
15,700 |
$2.17 |
$34.07K |
15,700 |
| 2024-08-12 |
Kollintzas Dean G |
Director |
RSU Award |
8,050 |
$2.17 |
$17.47K |
8,050 |
| 2024-08-12 |
Sharkey John W. |
VP, Business Development |
RSU Award |
15,700 |
$2.17 |
$34.07K |
15,700 |
| 2024-08-12 |
Mckee Kelly T. Jr. |
Chief Medical Officer |
RSU Award |
15,700 |
$2.17 |
$34.07K |
15,700 |
| 2024-08-12 |
Lemerond Nicole |
Director |
RSU Award |
8,050 |
$2.17 |
$17.47K |
8,050 |
| 2024-08-12 |
Morgan Jayne |
Director |
RSU Award |
8,050 |
$2.17 |
$17.47K |
8,050 |
| 2024-08-09 |
Dodd David A |
President, CEO |
Informative Buy |
8,000 |
$1.95 |
$15.6K |
26,661 |
| 2024-02-22 |
Dodd David A |
President, CEO |
Informative Buy |
8,209 |
$2.27 |
$18.66K |
18,661 |
| 2024-02-21 |
Dodd David A |
President, CEO |
Informative Buy |
520 |
$2.15 |
$1.12K |
10,452 |
| 2024-02-07 |
Reynolds Mark |
CFO |
Informative Buy |
2,000 |
$2.77 |
$5.54K |
7,213 |
| 2023-12-22 |
Mckee Kelly T. Jr. |
Chief Medical Officer |
Informative Buy |
6,944 |
$0.36 |
$2.5K |
35,782 |
| 2023-09-25 |
Mckee Kelly T. Jr. |
Chief Medical Officer |
Informative Buy |
9,653 |
$0.52 |
$5.02K |
28,838 |
| 2023-08-25 |
Dodd David A |
President, CEO |
Informative Buy |
35,087 |
$0.57 |
$20K |
148,957 |
| 2023-08-18 |
Reynolds Mark |
CFO |
Informative Buy |
10,000 |
$0.52 |
$5.18K |
78,184 |
| 2023-08-01 |
Mcnally Robert T |
Director |
RSU Award |
50,000 |
$0.76 |
$37.75K |
50,000 |
| 2023-08-01 |
Chase Randal D |
Director |
RSU Award |
50,000 |
$0.76 |
$37.75K |
50,000 |
| 2023-08-01 |
Dodd David A |
President, CEO |
RSU Award |
250,000 |
$0.76 |
$188.75K |
250,000 |
| 2023-08-01 |
Newman Mark J |
Chief Scientific Officer |
RSU Award |
100,000 |
$0.76 |
$75.5K |
100,000 |
| 2023-08-01 |
Spencer John N Jr |
Director |
RSU Award |
50,000 |
$0.76 |
$37.75K |
50,000 |
| 2023-08-01 |
Reynolds Mark |
CFO |
RSU Award |
100,000 |
$0.76 |
$75.5K |
100,000 |
| 2023-08-01 |
Kollintzas Dean G |
Director |
RSU Award |
50,000 |
$0.76 |
$37.75K |
50,000 |
| 2023-08-01 |
Sharkey John W. |
VP, Business Development |
RSU Award |
100,000 |
$0.76 |
$75.5K |
100,000 |
| 2023-08-01 |
Mckee Kelly T. Jr. |
Chief Medical Officer |
RSU Award |
15,000 |
$0.76 |
$11.33K |
15,000 |
| 2023-08-01 |
Lemerond Nicole |
Director |
RSU Award |
50,000 |
$0.76 |
$37.75K |
50,000 |
| 2023-08-01 |
Morgan Jayne |
Director |
RSU Award |
50,000 |
$0.76 |
$37.75K |
50,000 |
| 2023-04-24 |
Dodd David A |
President, CEO |
Informative Buy |
32,000 |
$0.64 |
$20.44K |
113,870 |
| 2023-04-20 |
Reynolds Mark |
CFO |
Informative Buy |
8,000 |
$0.63 |
$5.04K |
68,184 |
| 2022-12-07 |
Morgan Jayne |
Director |
Unknown |
- |
- |
- |
- |
| 2022-09-21 |
Chase Randal D |
Director |
Informative Buy |
10,000 |
$1.10 |
$11K |
36,613 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
